M

ANALYST NOTE: M (Macy's, Inc.) Date: 2026-06-13 Analyst: StoryStocks-Native Equity Research

1. Structural Readiness

Classification: CONFIRMED-ACTIVE

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Exposure: None

As of 2026-06-13, there is no named secular thesis attached to this position. This is a tactical, setup-led name. Conviction must be derived strictly from the quality of the technical structure (the confirmed coil) and the immediate business fundamentals reported in the most recent earnings cycle. No macroeconomic or long-term thematic arguments are being applied to this trade; the investment case rests on the execution of the "Reimagine" strategy and the strength of the Q1 2026 performance relative to the setup parameters.

3. Business Overview

Company: Macy's, Inc. Industry: Consumer Discretionary (Department Stores / Omnichannel Retail) Business Model: Multi-brand, multi-category, and multi-channel retailer operating a network of physical department stores, e-commerce platforms, and mobile applications.

Operational Highlights (as of Q1 2026):

• Sales Performance: The company delivered 3% comparable sales growth in Q1 2026, described by management as their "strongest first quarter since 2022." The "go-forward" Macy's brand specifically rose 3.1%.
• Brand Performance: Bloomingdale's achieved a positive 10.2% comparable sales increase, marking its highest first-quarter sales in its 154-year history.
• Channel Mix: Digital sales accounted for 34% of net sales in the 13 weeks ended May 2, 2026, up from 33% in the prior year period. Macy's nameplate accounted for 82% of total net sales.
• Strategic Expansion: The "Reimagine" initiative, focused on store transformation, expanded to 75 additional locations in Q1, bringing the total base to 200 locations.
• Merchandising: Management introduced new luxury brands including Chloe Ready-to-Wear, Isabel Marant, Phoebe Philo, and Park Denim. The Bluemercury subsidiary continues to operate as a premier luxury beauty and spa retailer.
• Guidance: Management raised full-year net sales guidance to approximately $21.5 billion to $21.75 billion, citing better-than-expected top and bottom-line results in Q1.
• Cost Structure: Gross margin rate declined 30 basis points year-over-year, attributed to a 30 basis point tariff impact.

4. Archetype and Conviction

Archetype: Quality Compounder (with Cyclical Recovery characteristics)

Rationale: The name fits the "Quality Compounder" archetype due to the demonstrated ability to generate structural growth (3% comps, highest Q1 in history) while executing a capital-efficient transformation ("Reimagine"). The business model leverages a broad spectrum of consumers (value-conscious to premium luxury) and a flexible omnichannel approach, allowing it to react to shifting demand.

Conviction Stack:

• Thesis Strength: Moderate. The lack of a named secular thesis limits the "story" to tactical execution, but the execution is currently strong.
• Evidence Quality: High. The evidence base is robust, with primary earnings transcripts and SEC filings confirming the sales growth, margin dynamics, and guidance raise.
• Structural Quality: High. The ATR at breakout (4.2%) falls within the historical "high" sweet spot (4–6%), indicating a setup with sufficient volatility to generate returns without the extreme risk of the >8% bucket.
• Rerating Potential: Moderate. The raise in full-year guidance and the record-breaking Bloomingdale's performance suggest the market may be re-rating the stock based on improved operational leverage, though the tariff headwind remains a near-term friction point.

Valuation Context: The financial spine indicates a forward consensus EPS of $2.1882 for FY1 and $2.17341 for FY2. The current price of $24.14 implies a forward P/E ratio of approximately 11x, which is consistent with a mature retailer showing signs of recovery.

5. Invalidations, Strengtheners, and Gaps

Invalidation Triggers:

• A significant deterioration in comparable sales growth in subsequent quarters that contradicts the "strongest Q1 since 2022" narrative.
• A failure to maintain the "Reimagine" expansion trajectory or a sharp decline in Bloomingdale's performance.

Strengtheners:

• Continued expansion of the "Reimagine" base beyond 200 locations.
• Sustained digital sales growth above the 34% threshold.
• Further margin expansion that offsets the tariff impact.
• Confirmation of the raised full-year guidance in subsequent quarters.

Evidence Gaps:

• Missing Evidence: There is no specific data provided regarding the *cash flow* impact of the "Reimagine" capex or the specific *inventory turnover* metrics for the new luxury brands introduced.
• Missing Evidence: No explicit data on the *customer retention* or *acquisition* costs associated with the new digital initiatives.
• Missing Evidence: No detailed breakdown of the *geographic* performance of the 200 "Reimagine" locations versus legacy stores.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Q1 2026 comps of 3% (strongest since 2022); Bloomingdale's highest Q1 sales in 154 years; raised full-year guidance to $21.5B-$21.75B; confirmed active coil structure with high ATR. Key risks: Tariff impact depressing gross margins; potential consumer spending slowdown in discretionary categories; execution risk on "Reimagine" store transformations. Sizing hint: Position size should reflect the high ATR volatility; standard sizing for a confirmed coil with a wide stop is appropriate, but monitor the -3.6% extension closely. Expected path: Management expects continued top-line growth driven by the Reimagine strategy and luxury brand expansion; structural implications suggest a potential re-rating if the raised guidance is met. Expected horizon: 3 to 6 months for the setup to play out relative to the next earnings cycle.